Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Essential cysteine-containing proteins in Dirofilaria immitis are a group of vital enzymes and structural proteins characterized by the presence of reactive thiol (sulfhydryl) groups (BenchChem, 2025). These proteins are primarily involved in the parasite's energy metabolism, specifically the glycolytic pathway, and its antioxidant defense systems, including enzymes like glutathione reductase and thioredoxin reductase (BenchChem, 2025; USP, 2008). Because adult heartworms reside in a low-oxygen environment and rely heavily on anaerobic glycolysis, these proteins are indispensable for their survival. Trivalent arsenical drugs, such as melarsomine dihydrochloride, target these proteins by forming stable covalent bonds with the cysteine residues, effectively inactivating the enzymes (Wikipedia, 2025; NCATS, 2016). This disruption of metabolic and redox homeostasis leads to the death of the adult worms. However, the use of drugs targeting these proteins requires careful clinical management due to the risk of host arsenic toxicity and the potential for pulmonary thromboembolism as the dead worms are cleared from the host's vasculature (USP, 2008; NIH, 1994). These proteins represent the primary target for adulticidal therapy in canine heartworm disease, and the specificity of arsenical drugs for the parasite's proteins over the host's is a key factor in their therapeutic index.
Covalent binding of trivalent arsenic to sulfhydryl (thiol) groups of cysteine residues, leading to the inhibition of essential metabolic and antioxidant enzymes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Essential cysteine-containing protein.